Global Insomnia Market Growth (Status and Outlook) 2023-2029

Global Insomnia Market Growth (Status and Outlook) 2023-2029

Insomnia is a sleep disorder where people have trouble sleeping. They may have difficulty falling asleep, or staying asleep as long as desired. Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood.

LPI (LP Information)' newest research report, the “Insomnia Industry Forecast” looks at past sales and reviews total world Insomnia sales in 2022, providing a comprehensive analysis by region and market sector of projected Insomnia sales for 2023 through 2029. With Insomnia sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insomnia industry.

This Insight Report provides a comprehensive analysis of the global Insomnia landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Insomnia portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Insomnia market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insomnia and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insomnia.

The global Insomnia market size is projected to grow from US$ 3810.2 million in 2022 to US$ 4856.5 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.

Sleep hygiene and lifestyle changes are typically the first treatment for insomnia. Sleep hygiene includes a consistent bedtime, exposure to sunlight, a quiet and dark room, and regular exercise. Cognitive behavioral therapy may be added to this. While sleeping pills may help, they are associated with injuries, dementia, and addiction.

This report presents a comprehensive overview, market shares, and growth opportunities of Insomnia market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Pharmacological Therapy
Non-pharmacological Therapy

Segmentation by application
Female
Male
Senior Citizens

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Eisai
Meda Consumer Healthcare
Takeda Pharmaceuticals
Pfizer
Sanofi
Vanda Pharmaceuticals
Pernix Therapeutics
Purdue Pharmaceuticals

Please note: The report will take approximately 2 business days to prepare and deliver.